ArticleScientific reports2025
P4HA1 facilitates SPP1+ tumor-associated macrophages by activating the hypoxia pathway in head and neck squamous cell carcinoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Tumor-associated macrophages (TAMs) with highly expressed secreted phosphoprotein 1 (SPP1) carry immunosuppressive property as a potential target for tumor metastasis. However, the mechanisms regulating SPP1 + TAMs in head and neck squamous cell carcinoma (HNSCC) remain poorly understood. This study employs a combination of single-cell and bulk RNA sequencing bioinformatics analysis to confirm the impact of TAMs with high levels of SPP1 on patient prognosis. Additionally, Key genes linked to SPP1 + macrophages were identified using weighted gene co-expression network analysis. A prognostic model was built using the Random Forest algorithm. Here we show, P4HA1 is strongly correlated with SPP1 + macrophages and holds significant value in predicting patient prognosis and diagnosis. In vitro experiments demonstrated that TAMs educated by HNSCC cells with knockdown P4HA1 expressed lower SPP1 level compared to the control group. Furthermore, Gene Set Variation Analysis and Gene Set Enrichment Analysis indicated that P4HA1 mediates the hypoxia pathway in HNSCC. In xenografts model, P4HA1 knockdown effectively suppressed tumor malignant progress, confirming that P4HA1 was positive correlation with SPP1 + TAMs and could mediate tumor hypoxia pathways. Overall, this study identified P4HA1 as a key gene involved in regulating SPP1 + TAMs through modulating hypoxia, providing a potential macrophage-centered therapeutic target in HNSCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.